SEC 13F Intelligence

Skandinaviska Enskilda Banken AB (Publ) / ABBV

Skandinaviska Enskilda Banken AB (Publ)’s Abbvie Inc Position

Does Skandinaviska Enskilda Banken AB (Publ) own Abbvie Inc (ABBV)? Not currently — the last reported position was 863.4K shares worth $197M in Q4 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$197M
Q4 2025
Shares
863.4K
% of Portfolio
+0.79%
Quarters Held
29
position exited

Position History ABBV

Reported value by quarter
Q4 ’18: $98MQ4 ’18Q1 ’19: $82MQ2 ’19: $98MQ3 ’19: $107MQ4 ’19: $54MQ4 ’19Q1 ’20: $45MQ2 ’20: $65MQ3 ’20: $63MQ4 ’20: $77MQ4 ’20Q1 ’21: $89MQ2 ’21: $96MQ3 ’21: $99MQ4 ’21: $195MQ4 ’21Q1 ’22: $213MQ2 ’22: $181MQ3 ’22: $142MQ4 ’22: $130,355Q4 ’22Q1 ’23: $100,870Q2 ’23: $114,138Q3 ’23: $180,283Q4 ’23: $195MQ4 ’23Q1 ’24: $278MQ2 ’24: $261MQ3 ’24: $266MQ4 ’24: $176MQ4 ’24Q1 ’25: $188MQ2 ’25: $164MQ3 ’25: $220MQ4 ’25: $197MQ4 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q4 2025863.4K$197M+0.79%
Q3 2025947.4K$220M+0.88%
Q2 2025884.4K$164M+0.72%
Q1 2025894.5K$188M+0.92%
Q4 2024996.2K$176M+0.79%
Q3 20241.35M$266M+1.23%
Q2 20241.52M$261M+1.25%
Q1 20241.53M$278M+1.36%
Q4 20231.26M$195M+1.13%
Q3 20231.21M$180,283+1.18%
Q2 2023846.3K$114,138+0.75%
Q1 2023632.9K$100,870+0.70%
Q4 2022807.4K$130,355+0.98%
Q3 20221.06M$142M+1.10%
Q2 20221.18M$181M+1.33%
Q1 20221.31M$213M+1.25%
Q4 20211.43M$195M+1.00%
Q3 2021919.6K$99M+0.54%
Q2 2021855.5K$96M+0.59%
Q1 2021818.1K$89M+0.58%
Q4 2020720.4K$77M+0.53%
Q3 2020716.7K$63M+0.46%
Q2 2020660.0K$65M+0.52%
Q1 2020586.8K$45M+0.48%
Q4 2019609.2K$54M+0.42%
Q3 20191.41M$107M+0.90%
Q2 20191.35M$98M+0.85%
Q1 20191.01M$82M+0.75%
Q4 20181.06M$98M+0.88%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Skandinaviska Enskilda Banken AB (Publ)’s full portfolio or all institutional holders of ABBV.